← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$3.5M

Shares

259,259

Price

$14

Filed

Apr 25

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Slingsby Brian Taylor

Title

CIK

0001963901

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-03-13

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

8,903,838

Footnotes

Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Filing Info

Accession No.

0001933414-25-000052

Form Type

4

Issuer CIK

0001933414

Slingsby Brian Taylor's History

Date Ticker Type Value
2025-11-20 MLYS $43.4M
2025-03-13 MLYS $3.5M

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31